Where does Andrew Lam work?

Andrew Lam is Managing Director, Head of Biotech Private Equity at Ally Bridge Group and Board director at Epicrispr Biotechnologies.

Andrew Lam

Investor

Managing Director, Head of Biotech Private Equity at Ally Bridge Group · Board director at Epicrispr Biotechnologies

Find your path to Andrew

10 people in our graph share verified history with Andrew — schools, employers, funds. One of them is your warm intro.

Eric KwongunlockedAndrew: together at Ally Bridge Group

×8Andrew: together at Ally Bridge Group

Andrew: together at Epicrispr Biotechnologies

About

Managing Director and Head of Biotech Private Equity at Ally Bridge Group who led the firm's investment in Epicrispr and joined its board of directors.

Board director at Epicrispr Biotechnologies

Intro paths

→

In turn, Andrew can intro founders to Epicrispr Biotechnologies's investors below.

Epicrispr Biotechnologies's investors · 6

abrdn plcEdinburgh Ally Bridge GroupNew York · since 2018 Angelini VenturesRome Fidelity InvestmentsBoston Janus Henderson InvestorsNew York · since 2026 Sanofi VenturesCambridge · $5M checks · since 2026

Co-founders at Epicrispr Biotechnologies

Lei Stanley QiScientific Founder

Colleagues at Ally Bridge Group

Carlos Solórzano

Principal at S32

Frank Yu

Investor at Ally Bridge Group

Kevin Reilly

Managing Director and Head of MedTech Investments at Ally Bridge Group

Megan MacDonagh

Senior Associate at SV Health Investors

Slanix Paul Alex

President and Portfolio Manager, Public Equity at Ally Bridge Group

Steven Plachtyna

Investor at Ally Bridge Group

Frequently asked questions

Who is Andrew Lam?: Managing Director and Head of Biotech Private Equity at Ally Bridge Group who led the firm's investment in Epicrispr and joined its board of directors.
Where does Andrew Lam work?: Andrew Lam is Managing Director, Head of Biotech Private Equity at Ally Bridge Group and Board director at Epicrispr Biotechnologies.